Topics will include:
- The Sunshine Act’s intended goals – One step forward for patient care or one step back for industry? Neither or both?
- The covered manufacturers and GPOs required to report under the Sunshine Act.
- Defining, tracking and reporting "payment(s) or other transfer(s) of value" to physicians and teaching hospitals.
- The new rules and deadlines related to the Act – When tracking must really begin.
- Recommended internal compliance strategies for sales staff, vendors, meeting organizers, etc.
- Navigating related state laws and pending state legislation.
- Facilitating future treatments, scientific advances and intellectual property protection while complying with state and federal obligations.
The Sunshine Act–Best Practices for Industry Compliance and the Pathway to Improved Patient Care
When/Where:
Wednesday, September 12, 2012
2:00 PM - 3:30 PM Eastern (11:00 AM - 12:30 PM Pacific)
Webinar
Speakers:
- Ralph Hall, Faegre Baker Daniels
- Saul Helman, M.D., Navigant Consulting
- Cynthia Cetani, Vice President of Ethics and Compliance and Chief Compliance Officer of Novartis Pharmaceutical Corporations.
CLE is approved or in the process of approval for the mandatory CLE states listed below for 1.5 hours of CLE Credit. Of these, 1.5 qualify as hours of general, participatory, or skills credit, 0 qualify for hours of law office management, and 0 qualify for hours of ethics/professionalism.
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York†, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
More Information and Registration
No comments:
Post a Comment